Jan 25, 05
|
| 08:04 ET |
Alnylam Initiates Program to Develop RNAi Therapeutics for Spinal Cord Injury
|
|
Jan 20, 05
|
| 08:02 ET |
Alnylam to Webcast Presentation at Piper Jaffray Health Care Conference on January 27, 2005
|
|
Jan 10, 05
|
| 08:01 ET |
Alnylam Scientists Report Progress on RSV Program and Systemic RNAi Therapeutics
|
|
Jan 06, 05
|
| 08:31 ET |
Alnylam to Webcast Presentation at 23rd Annual JPMorgan Healthcare Conference on January 12, 2005
|
|
| 08:03 ET |
Alnylam Pharmaceuticals Grants GeneCare Research Institute Licenses to Fundamental Intellectual Property for RNAi Therapeutics Directed Against Two Gene Targets
|
|
Jan 04, 05
|
| 08:04 ET |
Alnylam Pharmaceuticals Initiates RNAi Therapeutic Development Program for Respiratory Syncytial Virus Infection
|
|
Jan 03, 05
|
| 08:01 ET |
Alnylam Reports Progress in Strategic Alliance with Merck
|
|
Dec 08, 04
|
| 08:02 ET |
Alnylam Pharmaceuticals Presents Results Showing Potential of RNA Interference Therapeutics for Age-Related Macular Degeneration and Other Ocular Diseases
|
|
Nov 10, 04
|
| 16:01 ET |
Alnylam Pharmaceuticals Reports Third Quarter 2004 Financial Results
|
|
| 13:00 ET |
First In Vivo Demonstration of RNA Interference via Systemic Delivery is Published by Alnylam Scientists
|
|
Oct 27, 04
|
| 16:03 ET |
Alnylam Pharmaceuticals Presents Results Showing Reduction Of Alpha-Synuclein Expression By RNA Interference
|
|
Oct 25, 04
|
| 08:03 ET |
Alnylam to Webcast Conference Call Discussing Third Quarter 2004 Financial Results
|
|
Oct 19, 04
|
| 08:33 ET |
Alnylam and Isis Receive Exclusive License to Key microRNA Patents for Therapeutic Applications
|
|
Oct 18, 04
|
| 08:32 ET |
Alnylam to Webcast Presentation at Rodman & Renshaw Techvest 6th Annual Healthcare Conference on October 26, 2004
|
|
Sep 15, 04
|
| 08:30 ET |
Alnylam to Webcast Presentation at ThinkEquity Partners 2nd Annual Growth Conference on September 22, 2004
|
|
Sep 13, 04
|
| 08:07 ET |
Alnylam Pharmaceuticals Appoints Robert Millman as Chief Patent Counsel
|
|
Aug 04, 04
|
| 16:08 ET |
Alnylam Pharmaceuticals Reports Second Quarter 2004 Financial Results
|
|
Aug 03, 04
|
| 17:15 ET |
Alnylam to Webcast Presentation at the 24th Annual Adams, Harkness & Hill Summer Seminar on August 5, 2004
|
|
| 17:15 ET |
Hybridon Licenses Key VEGF Patents to Alnylam for Treatment of Ocular Diseases with RNAi Therapeutics
|
|
Jul 28, 04
|
| 09:01 ET |
Alnylam to Webcast Conference Call Discussing Second Quarter 2004 Financial Results
|
|
Jul 23, 04
|
| 09:02 ET |
Alnylam to Webcast Presentation at Banc Of America Securities 'New Products, New Paradigms In Health Care' Conference on July 29, 2004
|
|
Jul 19, 04
|
| 16:10 ET |
Alnylam Pharmaceuticals Announces Management Change
|
|
Jun 24, 04
|
| 09:01 ET |
Alnylam Pharmaceuticals Appoints Patricia Allen as Vice President of Finance
|
|
Jun 07, 04
|
| 08:33 ET |
Alnylam Pharmaceuticals Announces Exercise of Underwriters' Over-Allotment Option
|
|
May 27, 04
|
| 18:52 ET |
Alnylam Pharmaceuticals Announces Pricing of Initial Public Offering
|
|